Tool profile
iblai/os
github.com
Open-source platform to build, deploy and manage customizable AI agents with any LLM provider.
What it does
iblai/os
ibl.ai/os is an open-source AI agent platform for creating and deploying customizable conversational agents with multiple LLM providers, real-time chat, voice, document training, analytics, user management and SSO. It targets organizations and developers who want a self-hostable, enterprise-ready agent stack across web, desktop and mobile. It is MIT-licensed and written in TypeScript.
PricingOpen source
RatingN/A
Bookmarks0
Tags
Categories
A concise summary has not been added yet.
FAQ
Frequently asked questions
- What is iblai/os?
- ibl.ai/os is an open-source AI agent platform for creating and deploying customizable conversational agents with multiple LLM providers, real-time chat, voice, document training, analytics, user management and SSO. It targets organizations and developers who want a self-hostable, enterprise-ready agent stack across web, desktop and mobile. It is MIT-licensed and written in TypeScript.
- How much does iblai/os cost?
- iblai/os uses a Open source pricing model. Check the official website for current plans.
- What is iblai/os used for?
- iblai/os is listed on TolsAI under: Open Source.
- Where can I use iblai/os?
- iblai/os is available on its official website, github.com.
Explore
More in Open Source
An open-source agentic harness for a self-improving AI agent that plans and executes tasks you describe.
A vectorless, reasoning-based RAG engine that indexes documents as trees and retrieves with LLM reasoning.
A PyTorch-like Python library to build and auto-optimize LLM workflows such as chatbots, RAG and agents.
A modular web UI for generating images, video and audio with AI models like Stable Diffusion, Flux and Wan.
A step-by-step guide to designing AI systems built on LLMs, RAG, and AI agents.
Open-source AI pipeline engine for building, debugging and deploying LLM workflows and agent orchestration from your IDE.
Discussion
Discussion
Log in to join the discussion
No comments yet. Start the discussion.